- Investing Ideas
- Taiwanese Transformative Artificial intelligence (AI) Healthcare Stocks
Taiwanese Transformative Artificial intelligence (AI) Healthcare Stocks
Results
9
Artificial intelligence (AI) is set to transform healthcare by enhancing diagnostics, personalizing medicine, boosting operational efficiency, expanding remote care, and accelerating research. AI outperforms humans in detecting diseases like cancer from scans, tailors treatments using genetic and lifestyle data, and streamlines hospital workflows with tools like predictive analytics and automated transcription. It powers telemedicine, monitors chronic conditions in real-time, and speeds up drug discovery by analyzing vast datasets for insights into complex diseases. Despite challenges like data privacy, bias, and integration costs, AI’s ability to improve accuracy, access, and affordability could save billions and extend lives, marking a seismic shift in healthcare delivery and outcomes.
9 companies
aetherAI
Market Cap: NT$2.2b
Provides medical image AI solution in Taiwan, Japan, and Germany.
7803
NT$22.80
7D
0.4%
1Y
-28.7%
AmCad BioMed
Market Cap: NT$690.3m
Develops computer-aided detection and diagnosis (CAD) software devices primarily in Taiwan.
4188
NT$10.50
7D
-5.0%
1Y
-35.2%
Senhwa Biosciences
Market Cap: NT$4.0b
A drug development company, engages in the development of new drugs and targeted agents.
6492
NT$44.00
7D
-2.5%
1Y
32.5%
Medimaging Integrated Solution
Market Cap: NT$2.3b
Engages in the design, manufacture and sale of digital medical imaging diagnostic equipments.
6796
NT$59.90
7D
-3.2%
1Y
-19.8%
Ever Fortune.AI
Market Cap: NT$5.7b
An cloud-based biomedical platform, provides medical artificial intelligence solutions and services in China.
6841
NT$63.10
7D
11.9%
1Y
-6.9%
Acer Medical
Market Cap: NT$1.5b
Offers artificial intelligence, clinical data, and software for healthcare sector.
6857
NT$95.00
7D
-2.6%
1Y
-19.5%
Yoda Pharmaceuticals
Market Cap: NT$3.2b
An AI-driven company, focuses on development of drugs targeting central nervous system disorders.
7829
NT$41.05
7D
-10.6%
1Y
14.7%
Onyx Healthcare
Market Cap: NT$4.4b
A professional medical IT company, engages in the design, manufacture, and trade of medical computers and peripherals for hospital/clinical IT market in Taiwan, the United States, and internationally.
6569
NT$112.50
7D
9.8%
1Y
-4.7%
INTAI Technology
Market Cap: NT$6.2b
Produces and sells medical equipment and precision fasteners.
4163
NT$114.00
7D
-5.8%
1Y
13.4%